Opioid neurotoxicity: Neuropathologic effects in rats of different fentanyl congeners and the effects of hexamethonium-induced normotension

Anesthesia and Analgesia

Volumn 83, Issue 1, 1996, Pages 141-146

  Kofke, W Andrew ^a   Garman, Robert H ^a   Janosky, Janine ^a   Rose, Marie E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; FENTANYL CITRATE; FENTANYL DERIVATIVE; HALOTHANE; HEXAMETHONIUM; NITROUS OXIDE; OPIATE DERIVATIVE; PANCURONIUM; SUFENTANIL CITRATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRAIN INJURY; CONTROLLED STUDY; DRUG MEGADOSE; HYPERTENSION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIMBIC SYSTEM; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS, OPIOID; ANIMALS; BLOOD GLUCOSE; BODY TEMPERATURE; FENTANYL; GANGLIONIC BLOCKERS; HEXAMETHONIUM; LIMBIC SYSTEM; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029995917     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199607000-00025     Document Type: Article

References (26)

1. Tommasino C, Maekawa T, Shapiro HM, et al. Fentanylinduced seizures activate subcortical brain metabolism. Anesthesiology 1984p60:283-90.
2. Young ML, Smith DS, Greenburg J, et al. Effects of sufentanil on regional cerebral glucose utilization in rats. Anesthesiology 1984;61:564-8.
3. Kofke WA, Garman RH, Tom WC, et al. Alfentanil-induced hypermetabolism, seizure, and histopathology in rat brain. Anesth Analg 1992;75:953-64.
4. Shingu K, Eger EI II, Johnson BH, et al. MAC values of thiopental and fentanyl in rats. Anesth Analg 1983;62:151-4.
5. Lozito RJ, La Marca S, Dunn RW, et al. Single versus multiple infusions of fentanyl analogues in a rat EEC model. Life Sci 1994;55:1337-42.
6. Kissin I, Kerr CR, Smith LR. Assessment of anesthetic action of morphine and fentanyl in rats. Can Anaesth Soc J 1983;30:623-8.
7. Levine S. Anoxic-ischemic encephalopathy in rats. Am J Pathol 1960;36:1-17.
8. Sinz EH, Kofke WA, Carman RH. Phenytoin, midazolam, and naloxone protect against fentanyl-induced brain damage in rats. J Neurosurg Anesth 1995;7:301.
9. Howse DC, Caronna JJ, Duffy TE, et al. Cerebral energy metabolism, pH, and blood flow during seizures in the cat. Am J Physiol 1974;227:1444-51.
10. Blennow G, Brierley JB, Meldrum BS, et al. Epileptic brain damage: the role of systemic factors that modify cerebral energy metabolism. Brain 1978;101:687-700.
11. Soderfeldt B, Blennow G, Kalimo H, et al. Influence of systemic factors on experimental epileptic brain injury. Structural changes accompanying bicuculline-induced seizures in rats following manipulations of tissue oxygenation or alpha-tocopherol levels. Acta Neuropathol 1983;60:81-91.
12. Blennow G, Nilsson B, Siesjo BK. Influence of reduced oxygen availability on cerebral metabolic changes during bicuculline-induced seizures in rats. J Cereb Blood Flow Metab 1985;5:439-45.
13. Asghar K, Roth LJ. Entry and distribution of hexamethonium in the central nervous system. Biochem Pharmacol 1971;20:- 2787-95.
14. Volle RL. The actions of several ganglion blocking agents on the postganglionic discharge induced by disopropyl, phosphorofluoridate (DFP) in sympathetic ganglia. J Pharmacol Exp Ther 1962;135:45-53.
15. Reid JL, Kopin IJ. The effects of ganglionic blockade, reserpine and vinblastine on plasma catecholamines and dopamine-betahydroxylase in the rat. J Pharmacol Exp Ther 1975;193:748-56.
16. Werner C, Hoffman WE, Thomas C, et al. Ganglionic blockade improves neurologic outcome from incomplete ischemia in rats: partial reversal by exogenous catecholamines. Anesthesiology 1990;73:923-9.
17. Stein SC, Cracco RQ. Cortical injury without ischemia produced by topical monamines. Stroke 1982;13:74-83.
18. Busto R, Harik SI, Yoshida S, et al. Cerebral norepinephrine depletion enhances recovery after brain ischemia. Ann Neurol 1985;18:329-36.
19. Kokaia M, Bengzon J, Kalen P, et al. Noradrenergic mechanisms in hippocampal kindling with rapidly recurring seizures. Brain Res 1989;491:398-402.
20. Minamisawa H, Smith ML, Siesjo BK. The effect of mild hyperthermia and hypothermia on brain damage following 5, 10, and 15 minutes of forebrain ischemia. Ann Neurol 1990;28:26-33.
21. Siemkowicz E. The effect of glucose upon restitution after transient cerebral ischemia: a summary. Acta Neurol Scand 1985;71:417-27.
22. Ingvar M, Folbegrova J, Siesjo BK. Metabolic alterations underlying the development of hypermetabolic necrosis in the substantia nigra in status epilepticus. J Cereb Blood Flow Metab 1987;7:103-8.
23. Swan JH, Meldrum BS, Simon RP. Hyperglycemia does not augment neuronal damage in experimental status epilepticus. Neurology 1986;36:1351-4.
24. Kofke WA, Ahdab-Barmada M, Rose M, et al. Substantia nigra damage after fluorothyl-induced seizures in rats worsens after post-seizure recovery: no exacerbation with hyperglycaemia. Neurol Res 1993;15:333-8.
25. Kearse LA Jr, Koski G, Husain MV, et al. Epileptiform activity during opioid anesthesia. Electroencephalogr Clin Neurophysiol 1993;87:374-9.
26. Kofke WA, Mintun M, Nemoto E, et al. Opioid neurotoxicity: preliminary studies in monkeys undergoing positron emission tomographic (PET) assessment of regional glucose utilization [abstract]. J Neurosurg Anesth 1994;6:323.